Updated on: 17 February 2021

Roles in: Z_INACTIVE_Gut Group

1. In the past 36 months have you accepted the following from a commercial organisation with a financial interest in the broad topic area of the Group/Unit?

a) Support for attending meetings, including sabbaticals and study tours (this covers travel, accommodation and/or hospitality)?
Yes - Compensated for travel to an investigators' meeting in Budapest in February 2020 by Phathom Pharmaceuticals

b) Payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events?
Yes - Within the past 3 years (2018-2021), I have bee a speaker for RedHill Biopharma, Alnylam, Alfasigma, Otsuka, Horizon

c) Fees for organising education?
No

d) Grants and contracts?
No

e) Funds for a member of staff?
No

f) Fees for consulting?
Yes - During the past 3 years (2018 - 2021), I have consulted for Redhill Biopharma, Phathom Pharmaceuticals, Ironwood, Alfasigma, US WorldMeds, Pfizer Consumer Health, Clexio

g) Royalty or licences payments?
No

h) Payment for expert testimony?
No

i) Payment for a fellowship?
No

j) Payment for participation on a Data Safety Monitoring Board, Advisory Board, or Guideline Panel?
Yes - I was a member of the Data Safety Monitoring Board for a clinical trial sponsored by EndoStim.

k) Payment for a leadership or other fiduciary role in other board, society, committee, or advocacy group?
No

2. In the past 36 months have you, your spouse/partner or an immediate family member been employed by or do you or they own a commercial organization with a financial interest in the broad topic area of the Group/Unit?
No

3. Do you own stocks or shares in a commercial organization with a financial interest in the broad topic area of the Group/Unit?
Yes - Since 2019, I have owned stock in Antibe Therapeutics.

4. Do you hold any patents (planned, issued or pending) for products relevant to the broad topic area of the Group/Unit?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - Since 2016, I have been co-Editor of Alimentary Pharmacology & Therapeutics.